CN Patent

CN104884458A — 作为蛋白质激酶抑制剂的稠合杂环化合物

Assigned to Beone Pharmaceutical Suzhou Co Ltd · Expires 2015-09-02 · 11y expired

What this patent protects

本发明涉及式(I)的稠合杂环化合物、其盐、其组合物，和其使用方法。具体而言，本文公开了可用于抑制蛋白激酶，包括布鲁顿酪氨酸激酶(Btk)和用于治疗由该激酶介导的疾病的某些稠合杂环化合物。

USPTO Abstract

本发明涉及式(I)的稠合杂环化合物、其盐、其组合物，和其使用方法。具体而言，本文公开了可用于抑制蛋白激酶，包括布鲁顿酪氨酸激酶(Btk)和用于治疗由该激酶介导的疾病的某些稠合杂环化合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN104884458A
Jurisdiction
CN
Classification
—
Expires
2015-09-02
Drug substance claim
No
Drug product claim
No
Assignee
Beone Pharmaceutical Suzhou Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.